| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The cytotoxic protein YopE of Yersinia obstructs the primary host defence.
|
Mol Microbiol
|
1990
|
5.09
|
|
2
|
Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption.
|
Infect Immun
|
1991
|
4.46
|
|
3
|
A secreted protein kinase of Yersinia pseudotuberculosis is an indispensable virulence determinant.
|
Nature
|
1993
|
3.40
|
|
4
|
Analysis of the V antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV.
|
J Bacteriol
|
1991
|
3.32
|
|
5
|
Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments.
|
Mol Microbiol
|
1997
|
2.40
|
|
6
|
The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation.
|
Mol Microbiol
|
1999
|
2.37
|
|
7
|
Functional conservation of the secretion and translocation machinery for virulence proteins of yersiniae, salmonellae and shigellae.
|
EMBO J
|
1995
|
2.30
|
|
8
|
A novel protein, LcrQ, involved in the low-calcium response of Yersinia pseudotuberculosis shows extensive homology to YopH.
|
J Bacteriol
|
1992
|
2.11
|
|
9
|
Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp.
|
Infect Immun
|
1988
|
1.90
|
|
10
|
Bacterial evasion of host immune defense: Yersinia enterocolitica encodes a suppressor for tumor necrosis factor alpha expression.
|
Infect Immun
|
1995
|
1.85
|
|
11
|
YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.
|
Mol Microbiol
|
1997
|
1.74
|
|
12
|
A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization.
|
Clin Exp Allergy
|
2011
|
1.66
|
|
13
|
The chaperone-like protein YerA of Yersinia pseudotuberculosis stabilizes YopE in the cytoplasm but is dispensible for targeting to the secretion loci.
|
Mol Microbiol
|
1995
|
1.64
|
|
14
|
Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis.
|
Mol Microbiol
|
1998
|
1.47
|
|
15
|
Virulence plasmid-encoded YopK is essential for Yersinia pseudotuberculosis to cause systemic infection in mice.
|
Infect Immun
|
1995
|
1.36
|
|
16
|
Construction of a reporter plasmid for screening in vivo promoter activity in Francisella tularensis.
|
FEMS Microbiol Lett
|
2001
|
1.32
|
|
17
|
Murine toxin of Yersinia pestis shows phospholipase D activity but is not required for virulence in mice.
|
Int J Med Microbiol
|
2000
|
1.28
|
|
18
|
The relationship between body mass and oxygen uptake during running in humans.
|
Med Sci Sports Exerc
|
1991
|
1.22
|
|
19
|
Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria.
|
Infect Immun
|
2000
|
1.09
|
|
20
|
Influence of body mass on cross-country ski racing performance.
|
Med Sci Sports Exerc
|
1992
|
1.06
|
|
21
|
Localization of the Yersinia PTPase to focal complexes is an important virulence mechanism.
|
Mol Microbiol
|
1999
|
1.06
|
|
22
|
Kinetics for the inhibition of acetylcholinesterase from the electric eel by some organophosphates and carbamates.
|
Eur J Biochem
|
1984
|
1.01
|
|
23
|
Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague.
|
Microb Pathog
|
1999
|
0.95
|
|
24
|
Genetic analysis of virulence determinants unique to Yersinia pestis.
|
Contrib Microbiol Immunol
|
1995
|
0.94
|
|
25
|
[(11)C]-PIB imaging in patients with Parkinson's disease: preliminary results.
|
Parkinsonism Relat Disord
|
2007
|
0.93
|
|
26
|
The Yersinia YopE and YopH type III effector proteins enhance bacterial proliferation following contact with eukaryotic cells.
|
BMC Microbiol
|
2001
|
0.92
|
|
27
|
Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.
|
J Neural Transm (Vienna)
|
2005
|
0.91
|
|
28
|
Marker proteins of platelet activation in patients with cerebrovascular disease.
|
Arch Neurol
|
1982
|
0.86
|
|
29
|
Microinjection of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption.
|
Biochem Soc Trans
|
1991
|
0.85
|
|
30
|
YopK, a novel virulence determinant of Yersinia pseudotuberculosis.
|
Contrib Microbiol Immunol
|
1995
|
0.85
|
|
31
|
Haemophilia utilization group study - Part Va (HUGS Va): design, methods and baseline data.
|
Haemophilia
|
2011
|
0.82
|
|
32
|
Concentrations of cadmium and other metals in Fucus vesiculosus L. and Fontinalis dalecarlica Br. Eur. from the northern Baltic Sea and the southern Bothnian Sea.
|
Environ Pollut
|
1988
|
0.79
|
|
33
|
Family presence and environmental factors at the time of a patient's death in an ICU.
|
Acta Anaesthesiol Scand
|
2007
|
0.79
|
|
34
|
Anterior tibial compartment pressure during race walking.
|
Am J Sports Med
|
1986
|
0.79
|
|
35
|
Relatives' experiences of visiting a conscious, mechanically ventilated patient--a hermeneutic study.
|
Intensive Crit Care Nurs
|
2010
|
0.78
|
|
36
|
Evaluation of image-enhanced paediatric computed tomography brain examinations.
|
Radiat Prot Dosimetry
|
2010
|
0.77
|
|
37
|
In vitro uptake of beta-alanine into rabbit retinal neurons.
|
Exp Brain Res
|
1974
|
0.77
|
|
38
|
Platelet activation and mitral valve prolapse.
|
Neurology
|
1983
|
0.77
|
|
39
|
Growth failure as a prognostic indicator for progression to acquired immunodeficiency syndrome in children with hemophilia.
|
J Pediatr
|
1990
|
0.76
|
|
40
|
The periodontal tissue of mandibular premolars and molars in some mammals. A comparative anatomical study.
|
Sven Tandlak Tidskr
|
1969
|
0.76
|
|
41
|
Morphological muscle characteristics in rowers.
|
Can J Appl Sport Sci
|
1980
|
0.75
|
|
42
|
[Psychodontia].
|
Sver Tandlakarforb Tidn
|
1968
|
0.75
|
|
43
|
Immunologic aberrations, HIV seropositivity and seroconversion rates in patients with hemophilia B.
|
Blood
|
1987
|
0.75
|
|
44
|
[Comments to a paper on aphthae].
|
Tandlakartidningen
|
1978
|
0.75
|
|
45
|
[Frequency of broken endodontic files].
|
Tandlakartidningen
|
1974
|
0.75
|
|
46
|
[Some impressions from a study trip to Japan].
|
Odontol Foren Tidskr
|
1970
|
0.75
|
|
47
|
[Fear of dental treatment].
|
Sven Tandlak Tidskr
|
1966
|
0.75
|
|
48
|
[Psychosomatic diseases. A short review].
|
Tandlakartidningen
|
1978
|
0.75
|
|
49
|
YerA mediates the secretion of the YopE cytotoxin of Yersinia pseudotuberculosis.
|
Contrib Microbiol Immunol
|
1995
|
0.75
|
|
50
|
Human immunodeficiency virus detection and differential leukocyte counts are accurate and safer with formaldehyde-fixed blood.
|
Blood
|
1993
|
0.75
|
|
51
|
High doses of fluoride do not affect cyclic AMP levels in human and rat plasma or urine.
|
Scand J Dent Res
|
1986
|
0.75
|
|
52
|
[What is adequate therapy by tension headache and temporomandibular joint dysfunctions?].
|
Tandlakartidningen
|
1978
|
0.75
|
|
53
|
[Psychodontics--a new subject for instruction].
|
Odontol Foren Tidskr
|
1969
|
0.75
|